Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-26

Clinical Trial Update: Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating dexamethasone for acute hypoxemic respiratory failure caused by infections and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Dr. Negrin University Hospital | Conditions: Acute Hypoxemic Respiratory Failure | Phase 4 | Status: RECRUITING